• Hepatitis Outlook: Late February 2017

    on March 22nd, 2017
    If you work on the front lines of medical care, treating patients with hepatitis, you may not have time to review all the hepatitis research that enters the medical literature every month. Here’s a quick look at some notable news items and journal articles published over the past month, which cove[...]
  • Psychological factors drive Crohn’s symptom reports

    on March 20th, 2017
    FROM THE JOURNAL OF PEDIATRICS Psychological factors, rather than disease activity, were significantly associated with symptoms in children and teens with Crohn’s disease, based on data from 127 children aged 8-18 years. Patients completed questionnaires on symptom severity and disability, as well[...]
  • Cardiovascular disease most common cause of death in CRC survivors

    on March 20th, 2017
    AT SSO 2017 SEATTLE (FRONTLINE MEDICAL NEWS) – Improvements in diagnosis and treatment have lengthened the survival time of patients with colorectal cancer, but the majority of deaths from CRC occur within the first 5 years. According to new findings presented at the annual Society of Surgical Onc[...]
  • VIDEO: Clear food labels may improve healthy habits

    on March 20th, 2017
    AT ACC 17 WASHINGTON (FRONTLINE MEDICAL NEWS) – Application clear graphic nutrition labels on the front of packaged foods could help patients make healthier food choices, according to a study out of the George Institute of Global Health, Sydney. Bruce Neal, PhD, senior director of the food policy [...]
  • Antiviral medication successful for treating HCV in hepatocellular carcinoma

    on March 16th, 2017
    FROM JOURNAL OF HEPATOLOGY Direct-acting antiviral (DAA) medication was successful in treating hepatitis C in 74.5% of patients with hepatocellular carcinoma, and 93.4% of patients with HCC who underwent liver transplants, according to a study funded by Veterans Affairs. In order to study the effect[...]
  • HCV ‘cure’ within the VA appears likely

    on March 16th, 2017
    FROM ALIMENTARY PHARMACOLOGY AND THERAPEUTICS The number of Veterans Affairs patients with hepatitis C who have achieved a sustained virologic response to antiviral therapy has escalated so rapidly and reached such a height that the disease may well be eradicated in that health care system within a [...]
  • Infant hepatitis B vaccine protection lingers into adolescence

    on March 15th, 2017
    FROM THE PEDIATRIC INFECTIOUS DISEASE JOURNAL Adolescents who received hepatitis B virus (HBV) vaccinations as infants still showed protection despite little evidence of residual antibodies, a study showed. This finding was based on data from a prospective study of 137 children, aged 10-11 years, an[...]
  • HCV testing stagnant among baby boomers

    on March 10th, 2017
    FROM AMERICAN JOURNAL OF PREVENTIVE MEDICINE Despite the urging of the United States Preventive Services Task Force and other organizations in 2013, the percentage of baby boomers who underwent testing for hepatitis C (HCV) infection had barely changed 2 years later – from 12.3% in 2013 to 13.8% i[...]
  • Norovirus reporting tool yields real-time outbreak data

    on March 9th, 2017
    from the morbidity and mortality weekly report NoroSTAT, the Centers for Disease Control and Prevention’s new program with which states can report norovirus outbreaks, yields more timely and more complete epidemiologic and laboratory data, which allows a faster and better-informed public health re[...]
  • Small study: Watchful waiting better for pediatric IBS

    on March 7th, 2017
    FROM THE JOURNAL OF PEDIATRICS Children with irritable bowel syndrome (IBS) may recover more successfully with reassurance than with medication, according to a study from Federico II University in Naples, Italy. Of 83 children in this single-center observational study, 30 of the 48 children (62.8%) [...]
  • Colorectal tumors: ESD passes long-term test

    on March 6th, 2017
    FROM GASTROINTESTINAL ENDOSCOPY Endoscopic submucosal dissection (ESD) of superficial colorectal tumors has a favorable long-term outcome, with 94.6% overall survival and 100% disease-specific survival at a median 79 months of follow-up, reported Kenjiro Shigita, MD, of the department of gastroenter[...]
  • Barrett’s esophagus: Cancer risk is highest in first year after diagnosis

    on March 6th, 2017
    FROM THE EUROPEAN JOURNAL OF CANCER The highest risk of diagnosis with esophageal adenocarcinoma occurs in the first month after diagnosis with Barrett’s esophagus (BE). Further, the risk of this type of esophageal cancer is lower than previously believed after that first year, according to a stud[...]
  • Point-of-care assay caught acetaminophen toxicity

    on March 3rd, 2017
    A rapid point-of-care assay for acetaminophen-related liver toxicity had a sensitivity of 100% and a specificity of 86%, compared with etiologic diagnosis, based on the results of a multicenter study published in the April issue of Clinical Gastroenterology and Hepatology. The test might help guide [...]
Back to top